[Therapeutic considerations in myasthenia gravis].
作者信息
Vejvalka J
出版信息
Cesk Neurol Neurochir. 1984 Mar;47(2):78-84.
PMID:6705094
Abstract
摘要
相似文献
1
[Therapeutic considerations in myasthenia gravis].
Cesk Neurol Neurochir. 1984 Mar;47(2):78-84.
2
[Myasthenia gravis. Recent findings and their therapeutic consequences].
Dtsch Med Wochenschr. 1979 Oct 5;104(40):1415-20. doi: 10.1055/s-0028-1129112.
3
Myasthenia gravis: clinical, immunological, and therapeutic advances.
Acta Neurol Scand. 2005 Feb;111(2):134-41. doi: 10.1111/j.1600-0404.2005.00374.x.
4
[Myasthenia gravis. Treatment].
Ugeskr Laeger. 1984 Jan 30;146(5):345-8.
5
Management of myasthenia gravis.
Semin Neurol. 2004 Mar;24(1):41-8. doi: 10.1055/s-2004-829586.
6
The treatment of patients with myasthenia gravis.
Neurol Clin. 1994 May;12(2):343-68.
7
[Current therapeutic aspects of myasthenia gravis].
Rev Clin Esp. 1981 Oct 31;163(2):139-44.
8
Therapeutic options in autoimmune myasthenia gravis.
Autoimmun Rev. 2007 Jun;6(6):373-8. doi: 10.1016/j.autrev.2007.01.001. Epub 2007 Jan 30.
9
[Therapy of myasthenia gravis].
Dtsch Med Wochenschr. 1977 Aug 12;102(32):1160-3. doi: 10.1055/s-0028-1105478.
10
[Treatment of myasthenia].
Rev Prat. 1979 Jun 21;29(35):2789-99.
Zotero 插件